Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2020-03-02 Annual Report
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
10-K
Annual Report FY 2019
2020-03-02 English
8-K
Remuneration Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on the approval of a 2020 Incentive Plan and details about executive compensation, bonus structures, and long-term incentive policies. It discusses management compensation plans and changes but does not contain full financial statements or comprehensive financial performance data. It is not an annual or quarterly report, nor is it an earnings release or audit report. The primary subject is related to management compensation and incentive plans, which aligns with Remuneration Information filings. Therefore, the document is best classified as Remuneration Information (DEF 14A).
2020-02-21 English
SCHEDULE 13G
Major Shareholding Notification
2020-02-20 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 19, 2020, by OraSure Technologies, Inc. It announces the release of the company's consolidated financial results for the full year and quarter ended December 31, 2019, and updated financial guidance. It also references a webcast conference call with prepared remarks from the CEO and CFO discussing these results. The document includes a press release and prepared remarks as exhibits. The content is typical of an Earnings Release (ER) as it provides initial announcement of quarterly and annual financial results with key highlights and guidance. The document is not a full annual report (10-K), nor an interim report (IR), but a current report announcing earnings results. Therefore, the appropriate classification is Earnings Release (ER). The document length (5396 characters) supports it being a substantive announcement rather than a brief report publication announcement (RPA).
2020-02-19 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-13 English
SCHEDULE 13G
Major Shareholding Notification
2020-02-12 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.